HC Wainwright Has Optimistic Outlook of CRBU Q2 Earnings
Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) – Equities research analysts at HC Wainwright lifted their Q2 2025 EPS estimates for Caribou Biosciences in a report released on Monday, April 28th. HC Wainwright analyst R. Burns now anticipates that the company will earn ($0.35) per share for the quarter, up from their prior estimate of […]
